With the onset of the Omicron variant and the opening of the vaccinated travel lane (VTL) arrangements, the company will increase its Covid-19 PCR testing services to include 10 Q&M Dental clinics by Dec 31.
Acumen Diagnostics, a 51%-owned subsidiary of Q&M Dental Group and 49%-owned by Aoxin Q&M Dental Group, says it has been granted a license by the Ministry of Health (MOH) to provide offsite Covid-19 polymerase chain reaction (PCR) swab services and serology sample collection.
Acumen Diagnostics will roll out its testing services via Q&M Dental’s clinics, as well as its headquarters at The Gemini at 41 Science Park.
